Endo Pharmaceuticals had a not so good week this week. The FDA has asked the company to remove its opioid pain medication, Opana ER, from the market. The firm stated that the “benefits of the drug may no longer outweigh its risks.” This is the very first time the FDA has asked a company to … Continue reading “FDA Ask A Major Pharma Company To Remove A Pain Drug From The Market”
